Skip to Main Content

Author Details

Claudio Schneider
Laboratorio Nazionale-Consorzio Interuniversitario per le Biotecnologie
1987
122
61
PMIDPaper TitleJournal TitlePublished Year
33741433Expression of the tumor-expressed protein MageB2 enhances rRNA transcription.Biochim Biophys Acta Mol Cell Res2021
33741433Expression of the tumor-expressed protein MageB2 enhances rRNA transcription.Biochim Biophys Acta Mol Cell Res2021
33128015FUS-dependent loading of SUV39H1 to OCT4 pseudogene-lncRNA programs a silencing complex with OCT4 promoter specificity.Commun Biol2020
33343767A Streamlined Approach to Rapidly Detect SARS-CoV-2 Infection Avoiding RNA Extraction: Workflow Validation.Dis Markers2020
33128015FUS-dependent loading of SUV39H1 to OCT4 pseudogene-lncRNA programs a silencing complex with OCT4 promoter specificity.Commun Biol2020
33343767A Streamlined Approach to Rapidly Detect SARS-CoV-2 Infection Avoiding RNA Extraction: Workflow Validation.Dis Markers2020
30335599USP1 (ubiquitin specific peptidase 1) targets ULK1 and regulates its cellular compartmentalization and autophagy.Autophagy2019
30335599USP1 (ubiquitin specific peptidase 1) targets ULK1 and regulates its cellular compartmentalization and autophagy.Autophagy2019
28850106FANTOM5 CAGE profiles of human and mouse samples.Sci Data2017
28542476Functional interaction between co-expressed MAGE-A proteins.PLoS One2017
28850106FANTOM5 CAGE profiles of human and mouse samples.Sci Data2017
28978043GTSE1: a novel TEAD4-E2F1 target gene involved in cell protrusions formation in triple-negative breast cancer cell models.Oncotarget2017
28754773Correction for Copetti et al., "p65/RelA Modulates <i>BECN1</i> Transcription and Autophagy".Mol Cell Biol2017
28319064OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness.Oncogene2017
28302665Calpain mobilizes Atg9/Bif-1 vesicles from Golgi stacks upon autophagy induction by thapsigargin.Biol Open2017
28302665Calpain mobilizes Atg9/Bif-1 vesicles from Golgi stacks upon autophagy induction by thapsigargin.Biol Open2017
28319064OCT4 controls mitotic stability and inactivates the RB tumor suppressor pathway to enhance ovarian cancer aggressiveness.Oncogene2017
28978043GTSE1: a novel TEAD4-E2F1 target gene involved in cell protrusions formation in triple-negative breast cancer cell models.Oncotarget2017
28542476Functional interaction between co-expressed MAGE-A proteins.PLoS One2017
28754773Correction for Copetti et al., "p65/RelA Modulates <i>BECN1</i> Transcription and Autophagy".Mol Cell Biol2017
26957525Thromboxane Governs the Differentiation of Adipose-Derived Stromal Cells Toward Endothelial Cells In Vitro and In Vivo.Circ Res2016
26957525Thromboxane Governs the Differentiation of Adipose-Derived Stromal Cells Toward Endothelial Cells In Vitro and In Vivo.Circ Res2016
26771715Calpain restrains the stem cells compartment in breast cancer.Cell Cycle2016
26771715Calpain restrains the stem cells compartment in breast cancer.Cell Cycle2016
26158551Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA.Nat Commun2015
26468294Human MageB2 Protein Expression Enhances E2F Transcriptional Activity, Cell Proliferation, and Resistance to Ribotoxic Stress.J Biol Chem2015
26158551Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA.Nat Commun2015
26468294Human MageB2 Protein Expression Enhances E2F Transcriptional Activity, Cell Proliferation, and Resistance to Ribotoxic Stress.J Biol Chem2015
24670764A promoter-level mammalian expression atlas.Nature2014
24670764A promoter-level mammalian expression atlas.Nature2014
24560816Is this the real time for genomics?Genomics2014
25069783Specific mesothelial signature marks the heterogeneity of mesenchymal stem cells from high-grade serous ovarian cancer.Stem Cells2014
24876105miR-155 drives telomere fragility in human breast cancer by targeting TRF1.Cancer Res2014
25069783Specific mesothelial signature marks the heterogeneity of mesenchymal stem cells from high-grade serous ovarian cancer.Stem Cells2014
24876105miR-155 drives telomere fragility in human breast cancer by targeting TRF1.Cancer Res2014
24560816Is this the real time for genomics?Genomics2014
23307555An Oct4-pRb axis, controlled by MiR-335, integrates stem cell self-renewal and cell cycle control.Stem Cells2013
23307555An Oct4-pRb axis, controlled by MiR-335, integrates stem cell self-renewal and cell cycle control.Stem Cells2013
23589330CAPNS1 regulates USP1 stability and maintenance of genome integrity.Mol Cell Biol2013
23589330CAPNS1 regulates USP1 stability and maintenance of genome integrity.Mol Cell Biol2013
22117195MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs.Cell Death Differ2012
22966490Guidelines for the use and interpretation of assays for monitoring autophagy.Autophagy2012
22664239Tumor-specific MAGE proteins as regulators of p53 function.Cancer Lett2012
23236459GTSE1 is a microtubule plus-end tracking protein that regulates EB1-dependent cell migration.PLoS One2012
22117195MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs.Cell Death Differ2012
23236459GTSE1 is a microtubule plus-end tracking protein that regulates EB1-dependent cell migration.PLoS One2012
22966490Guidelines for the use and interpretation of assays for monitoring autophagy.Autophagy2012
22664239Tumor-specific MAGE proteins as regulators of p53 function.Cancer Lett2012
21703415Effects of age and heart failure on human cardiac stem cell function.Am J Pathol2011
21703415Effects of age and heart failure on human cardiac stem cell function.Am J Pathol2011
  • 1 - 50 of 244

Recommended Authors

Institut Curie, PSL Research University
Career Start Year 2011
Number of shared co-authors 0
Institute for Research in Immunology and Cancer (IRIC)
Career Start Year 2004
Number of shared co-authors 1
The University of Hong Kong
Career Start Year 2003
Number of shared co-authors 0
Max Planck Institute of Molecular Cell Biology and Genetics
Career Start Year 2001
Number of shared co-authors 2
Amsterdam University Medical Centers location AMC
Career Start Year 1999
Number of shared co-authors 6
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 3
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Institut Curie, PSL Research University
Career Start Year 1996
Number of shared co-authors 0
University of the Basque Country (UPV/EHU)
Career Start Year 1995
Number of shared co-authors 6
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year 1992
Number of shared co-authors 2
Lilly Research Laboratories
Career Start Year 1992
Number of shared co-authors 0
National Institute of Child Health & Human Development, National Institutes of Health
Career Start Year 1991
Number of shared co-authors 0
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year 1991
Number of shared co-authors 2
National Human Genome Research Institute
Career Start Year 1990
Number of shared co-authors 1
carnegie mellon university - 1 rue Michel Servet CH-1 Geneva 4
Career Start Year 1989
Number of shared co-authors 19
Amsterdam University Medical Center
Career Start Year 1989
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 10
Cancer Center Amsterdam
Career Start Year 1988
Number of shared co-authors 2
Department of Oncology and Children's Research Center, University Children's Hospital
Career Start Year 1985
Number of shared co-authors 1
Hospital for Sick Children, University of Toronto
Career Start Year 1985
Number of shared co-authors 3
Moores Cancer Center, University of California San Diego
Career Start Year 1984
Number of shared co-authors 4
Neuroscience Institute, NYU Grossman School of Medicine
Career Start Year 1984
Number of shared co-authors 2
Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1982
Number of shared co-authors 10
UCL Institute of Prion Diseases
Career Start Year 1981
Number of shared co-authors 1
Tokyo University of Science
Career Start Year 1979
Number of shared co-authors 2
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 3
Frederick National Laboratory for Cancer Research
Career Start Year 1975
Number of shared co-authors 5
The Wistar Institute
Career Start Year 1975
Number of shared co-authors 3
University of Rochester Medical Center, Wilmot Cancer Institute
Career Start Year 1974
Number of shared co-authors 0
Salk Institute for Biological Studies
Career Start Year 1968
Number of shared co-authors 4

Collaborators

LNCIB - Consorzio Interuniversitario per le Biotecnologie c/o BIC Incubatori FVG
Co-authored papers 13
International Centre for Genetic Engineering and Biotechnology
Co-authored papers 12
Istituto Italiano di Tecnologia
Co-authored papers 11
RIKEN Center for Integrative Medical Sciences
Co-authored papers 10
University of Udine
Co-authored papers 8
Center for Integrative Medical Sciences
Co-authored papers 8
Co-authored papers 8
Weill-Cornell School of Medicine
Co-authored papers 7
Intractable Disease Research Center, Graduate School of Medicine, Juntendo University
Co-authored papers 6
RIKEN Center for Integrative Medical Sciences
Co-authored papers 6
Co-authored papers 5
RIKEN Center for Integrative Medical Sciences
Co-authored papers 5
University of Trento
Co-authored papers 5
RIKEN Center for Integrative Medical Sciences
Co-authored papers 5
RIKEN Center for Integrative Medical Sciences
Co-authored papers 5
RIKEN Center for Integrative Medical Sciences
Co-authored papers 4
Graduate School of Medicine, Osaka University
Co-authored papers 4
Tokyo University of Technology
Co-authored papers 4
RIKEN Center for Integrative Medical Sciences
Co-authored papers 4
The University of Melbourne
Co-authored papers 4
Karolinska Institutet
Co-authored papers 4
Mater Research Institute-UQ, Translational Research Institute
Co-authored papers 4
Institute of Genetics and Cancer, University of Edinburgh
Co-authored papers 3
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Co-authored papers 3
RIKEN Center for Integrative Medical Sciences
Co-authored papers 3
RIKEN Center for Integrative Medical Sciences
Co-authored papers 3
Simons Center for Systems Biology, Institute for Advanced Study
Co-authored papers 3
Institute of Genetics and Cancer, University of Edinburgh
Co-authored papers 3
Co-authored papers 3
Japan Tobacco Inc.
Co-authored papers 3